# Progress Note 05 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Muhammad Ali (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-BX001-SYN
- Date: 2026-10-06
- Fictional facility: St. Posthumous Health Center
- Fictional author: Celeste Moreau, MD
- Calendar frame: modern shifted

- Visit type: Preventive Visit
- Services: CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning), both on the same day

## Chief complaint

Periodic preventive visit; no new complaints. **S**

## History of present illness

Mr. Ali is a 54-year-old man with young-onset Parkinson's disease, diagnosed twelve years ago, who comes for his periodic preventive visit four weeks after his six-month Parkinson's disease review. He completed the health risk assessment before the visit. He takes carbidopa-levodopa one and a half tablets three times a day, 30 minutes before meals, with an alarm on his phone, and has missed no doses. He has had no falls, emergency visits, or hospital stays this year. He walks or rides a stationary bicycle and does his physical therapy balance exercises about 180 minutes a week, and practices his voice exercises daily. He has no new concerns. **S**

| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 54 |
| Safety events | No falls, emergency visits, or hospital stays this year |
| Medicines | Carbidopa-levodopa on time with phone alarms; no over-the-counter medicines or supplements |
| Active conditions | Parkinson's disease, Hoehn and Yahr stage 2.5, without dyskinesia or wearing-off; soft speech, improved after speech therapy |
| Functional status | Independent in all activities of daily living; Timed Up and Go 11 seconds at the six-month review |

## Health risk assessment

Completed by the patient before the visit and reviewed during the visit. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good |
| Psychosocial | Lives with his spouse; close family and friends; busy schedule of public and charitable appearances, which he enjoys |
| Tobacco | Never used tobacco |
| Alcohol and drugs | No alcohol (AUDIT-C 0); no other drug use |
| Physical activity | About 180 minutes a week of walking, stationary cycling, and balance exercises |
| Nutrition | Regular meals; takes levodopa 30 minutes before meals and spreads protein through the day |
| Sleep | About seven hours a night; no dream enactment; not sleepy in the daytime |
| Activities of daily living | Independent; buttoning and handwriting slow |
| Instrumental activities of daily living | Independent; staff help with travel arrangements |
| Home safety | Grab bars in the shower, night lights, no loose rugs; smoke detectors working |
| Falls | No falls this year |
| Hearing and vision | No hearing concern; small print slower to read; no eye examination on record in recent years |
| Safety | Wears a seat belt; drives only short local trips in daylight; no firearms in the home |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight stable; no fever, night sweats, or fatigue beyond his usual |
| Eyes | Negative | No eye pain or double vision |
| Ears, nose, mouth, and throat | Negative | No hearing loss, drooling, or trouble chewing or swallowing |
| Cardiovascular | Negative | No chest pain, palpitations, lightheadedness on standing, or ankle swelling |
| Respiratory | Negative | No cough or breathlessness; no choking with meals |
| Gastrointestinal | Negative | No constipation, nausea, heartburn, or blood in the stool |
| Genitourinary | Negative | No urinary urgency or nighttime urination beyond once |
| Musculoskeletal | Negative | No joint or back pain |
| Integumentary | Negative | No new or changing skin lesions |
| Neurological | Positive | Known tremor and slowness, better since the levodopa increase; no freezing, dyskinesia, or wearing-off |
| Psychiatric | Negative | Mood good; no anxiety, hallucinations, or impulse-control problems; PHQ-2 score 0 |
| Endocrine | Negative | No heat or cold intolerance, thirst, or frequent urination |
| Hematologic | Negative | No easy bruising or bleeding |

13 systems reviewed. **S**

## Current medications

- Carbidopa-levodopa 25/100 mg oral tablet, one and a half tablets by mouth three times daily, 30 minutes before meals **S**

## Allergies

- No known allergy **S**

## Objective

BP 124/78 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 101.2 kg; BMI 27.7 kg/m². All vital signs are synthetic.

PHQ-2: 0; AUDIT-C: 0; Total cholesterol: 192 mg/dL; HDL cholesterol: 50 mg/dL; LDL cholesterol: 118 mg/dL; Triglycerides: 120 mg/dL; HbA1c: 5.4%. All results are synthetic.

## Immunizations given today

- Influenza vaccine, 2026-2027 season **S**
- Pneumococcal conjugate vaccine PCV20 **S**
- Recombinant zoster vaccine, dose 1 of 2 **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Alert, humorous, and engaged; weight 101.2 kg, BMI 27.7 |
| Eyes | Pupils equal and reactive; reduced blink rate |
| Ears, nose, and throat | Canals and tympanic membranes normal; oropharynx clear; no pooling of saliva |
| Neck | No thyroid enlargement or nodes; no carotid bruits |
| Cardiovascular | Regular rhythm at 70 per minute; no murmur; no edema |
| Respiratory | Clear to auscultation bilaterally |
| Abdomen | Soft and non-tender; no masses or organ enlargement |
| Skin | No suspicious lesions |
| Neurological | Reduced facial expression; mild right-hand rest tremor; mild bradykinesia, better than in the spring; walks with good arm swing for him; no dyskinesia |
| Psychiatric | Euthymic; judgment and insight intact |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic preventive visit, age 54**. Health risk assessment reviewed and a written prevention plan given. Depression, anxiety, and alcohol screens are negative. Ten-year cardiovascular risk is about 5 percent by the pooled cohort equations, with no risk factor that would call for a statin. HbA1c 5.4 percent. **S**
   - Next preventive visit in one year.
2. **Parkinson's disease, Hoehn and Yahr stage 2.5** (G20.A1). Stable on carbidopa-levodopa 150 mg three times daily, with no dyskinesia or wearing-off and no falls. **S**
   - Continue carbidopa-levodopa without change.
   - Next quarterly Parkinson's disease review in about two months, and the yearly movement disorders review in the spring.
3. **Hypokinetic dysarthria with soft speech** (R47.1). Easier to hear since speech therapy; keeps up daily voice practice. **S**
   - Continue daily voice exercises; refresher speech therapy if his voice softens again.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 124/78 mmHg |
| Cholesterol screening and statin decision | Completed today | Total cholesterol 192, HDL 50, LDL 118, triglycerides 120 mg/dL. Ten-year risk about 5 percent with no diabetes, hypertension, dyslipidemia, or smoking, so a statin is not recommended; repeat in five years |
| Diabetes screening | Completed today | HbA1c 5.4 percent; overweight adult aged 35 to 70; repeat in three years |
| Healthy weight and activity | Completed today | BMI 27.7; counseled to keep up 150 minutes or more of weekly exercise, which also helps his balance and gait |
| Colorectal cancer screening | Ordered | No prior screening on record. Options discussed; he chose a yearly fecal immunochemical test, and a kit was given today. A positive test needs colonoscopy |
| Prostate cancer screening | Not indicated | Shared decision-making about PSA testing is recommended from age 55; to be discussed next year |
| Lung cancer and abdominal aortic aneurysm screening | Not indicated | Never used tobacco |
| Depression screening | Completed today | PHQ-2 score 0; PHQ-9 3 at the first visit this year |
| Anxiety screening | Completed today | GAD-2 score 0 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C score 0 |
| Hepatitis C and HIV screening | Ordered | One-time screening recommended for all adults in these age ranges; no prior result on record; drawn with his consent today |
| Hepatitis B screening | Ordered | One-time triple panel recommended for all adults; drawn with today's blood tests |
| Influenza vaccine, this season | Completed today | Given today |
| Pneumococcal vaccine | Completed today | PCV20 given today; a single dose is recommended for adults 50 and older |
| Recombinant zoster vaccine | Completed today | Dose 1 given today; dose 2 due in two to six months |
| COVID-19 vaccine, this season | Due | Recommended; he will get it at the pharmacy next week |
| Tetanus, diphtheria, and pertussis booster | Due | No dose on record in the past ten years; to be given with the second zoster dose |
| RSV vaccine | Not indicated | Recommended at 75 and older, and from 50 with conditions that raise risk; his Parkinson's disease is not causing swallowing or breathing problems. Review yearly |
| Dental examination | Referred | No dental visit on record; Parkinson's disease calls for a dental examination every six months; appointment arranged |
| Eye examination | Due | No eye examination on record in recent years; a comprehensive eye examination advised |
| Falls prevention | Completed today | No falls; Timed Up and Go 11 seconds at the six-month review; exercise and home-safety measures continue |

## Advance care planning

Voluntary advance care planning discussion of about 20 minutes, with his consent. He named a health care agent, and a health care proxy form was completed; the agent is recorded in the chart and is not named here. He said that what matters most to him is staying active, keeping up his appearances and charitable work, and being told plainly about his health so he can take part in every decision. The discussion covered how Parkinson's disease can change over many years and why his wishes should be revisited as it does. He chose not to record specific treatment preferences today. The plan will be revisited yearly and at any change in stage. **S**

## Guideline basis

- CMID: Clinical Monitoring Intelligence Database, Parkinson's disease monograph (2026), Aether Forge
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Quarterly Parkinson's disease review in about two months. Second zoster dose and the Tdap booster in two to six months. Dental appointment arranged. Return the stool test kit within two weeks. Next preventive visit in one year. **S**

